Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000384933

Medchemexpress LLC L-826266 | 244101-03-9 | 98.0% | 570.88 | 50 MG
SDP

Catalog No. 5000384933
Encompass_Preferred

L-826266 is a selective and competitive EP3 receptor antagonist that can be used for convulsive disorders research. It also prevents PGE2-induced decrease of Na+,K+-ATPase activity in adult rat hippocampal slices and delays and increases the latency for clonic and generalized tonic-clonic seizures induced by PTZ in animal models.

  • Selective and competitive EP3 receptor antagonist
  • Can be used for convulsive disorders research
  • Prevents PGE2-induced decrease of Na+,K+-ATPase activity in adult rat hippocampal slices
  • Delays and increases the latency for clonic and generalized tonic-clonic seizures induced by PTZ in animal models

Catalog No. 50-003-84933 Supplier Medchemexpress LLC Supplier No. HY1936150MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

L-826266 is a selective and competitive EP3 receptor antagonist that can be used for convulsive disorders research. It also prevents PGE2-induced decrease of Na+,K+-ATPase activity in adult rat hippocampal slices and delays and increases the latency for clonic and generalized tonic-clonic seizures induced by PTZ in animal models.

  • Selective and competitive EP3 receptor antagonist
  • Can be used for convulsive disorders research
  • Prevents PGE2-induced decrease of Na+,K+-ATPase activity in adult rat hippocampal slices
  • Delays and increases the latency for clonic and generalized tonic-clonic seizures induced by PTZ in animal models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.